首页> 外国专利> THERAPEUTIC AGENT FOR OVARIAN CLEAR CELL ADENOCARCINOMA TARGETED FOR N-myc DOWNSTREAM REGULATED GENE 1 PROTEIN

THERAPEUTIC AGENT FOR OVARIAN CLEAR CELL ADENOCARCINOMA TARGETED FOR N-myc DOWNSTREAM REGULATED GENE 1 PROTEIN

机译:针对N-myc下游调节基因1蛋白的卵巢透明细胞腺癌的治疗剂

摘要

PROBLEM TO BE SOLVED: To provide a new therapeutic agent for ovarian clear cell adenocarcinoma targeted for a protein specifically developed in this disease.;SOLUTION: A therapeutic agent and/or a preventive agent of clear cell adenocarcinoma includes a substance which can inhibit the function of or suppress the development of, the N-myc downstream regulated gene 1 protein in a clear cell adenocarcinoma cell. A drug that reduces the anticancer drug resistance of clear cell adenocarcinoma contains a substance which can inhibit the function of or suppress the development of, the N-myc downstream regulated gene 1 protein in a clear cell adenocarcinoma cell.;COPYRIGHT: (C)2013,JPO&INPIT
机译:要解决的问题:为卵巢透明细胞腺癌提供一种针对该疾病专门开发的蛋白质的新型治疗剂;解决方案:透明细胞腺癌的治疗剂和/或预防剂包括可抑制其功能的物质N-myc下游调节基因1蛋白在透明细胞腺癌细胞中的表达或抑制其发展。降低透明细胞腺癌的抗癌药抗性的药物包含一种可以抑制透明细胞腺癌细胞中N-myc下游调节基因1蛋白的功能或抑制其发展的物质.COPYRIGHT:(C)2013 ,JPO&INPIT

著录项

  • 公开/公告号JP2013040139A

    专利类型

  • 公开/公告日2013-02-28

    原文格式PDF

  • 申请/专利权人 YOKOHAMA CITY UNIV;

    申请/专利号JP20110178684

  • 申请日2011-08-18

  • 分类号A61K45/00;C12Q1/68;A61P35/00;G01N33/15;G01N33/50;G01N33/68;C12N5/09;C07K14/82;C12N15/09;

  • 国家 JP

  • 入库时间 2022-08-21 16:58:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号